Search
Search
Illumina
Instrument
- Data passing through the filter: the number of clusters passing through the filter ranges from 8-25 million - Capacity per run: ranges from 2.5 GB - 7.5 GB data output - Data Quality (Quality Score) > Q30 (accuracy 99.9%)
Model: MiniSeq
Manufacturer: Illumina/USA
– New generation DNA sequencing system using synthetic sequencing technology: Sequencing by Synthesis – SBS
– Next Generation Sequencing, allowing to run the entire DNA and RNA amplification process combined with sequencing analysis on a single system
– Maximum reading capacity: 7.5 Gb (equivalent to 7.5 billion bases) within 24 hours
– Data Quality (Quality Score) > Q30 (accuracy 99.9%)
– Whole-genome sequencing for small genomes (Small Whole-genome Resequencing)
– Targeted sequencing
– Sequencing to detect gene mutations related to colorectal cancer, lung cancer, … application in early screening and targeted treatment
– Sequencing mRNA, small RNA, micro RNA
– Paired-end sequencing of target amplicons
– Paired-end gene sequencing for target gene expression profiling
– Sequencing time when using the High-Output Reagent Kit
• Sequencing 1 x 50 bp in 7 hours (384 samples)
• Sequencing 2 x 75 bp in 13 h (23 samples)
• 24h 2 x 150 bp sequencing (50 small genome sequencing samples, 28 target amplicon sequencing samples)
Compatible with 2 types of flow cells with different capacities (large capacity and medium capacity), depending on the purpose of sequencing
– Data passing through the filter: the number of clusters passing through the filter ranges from 8-25 million
– Capacity per run: ranges from 2.5 GB – 7.5 GB data output
– Data Quality (Quality Score) > Q30 (accuracy 99.9%). Percentage of data with quality > 85% > Q30 (1-way solves 25 million readings, 2-way gets 50 million reads)
– Optical system using excitation LEDs (515 nm, 650 nm)
Fully automated process: 10 min of manual operation and 6 h of sequencing (1 x 36 bp) including clustering, sequencing, and automatic washing after run
– Has radio wave consumables (RFID – tracking) feature, using pre-loaded chemical cartridges
Running capacity: up to 384 samples can be analyzed in one sequencing
Supplier: Illumina
SOLIDaccuTest™ is an excellent tool to explorer variants associated with solid tumors using a comprehensive method of next-generation sequencing (NGS). It reflects the latest research trends and is optimized for the medical purpose by selecting essential genes of solid tumors including lung, colon, breast, skin brain, gastric, ovarian cancers, etc.
BRCAaccuTest™ PLUS with CE-IVD certificate for HBOC Breast/Ovarian Cancer Test
BRCAaccuTest™ & BRCAaccuTest™PLUS is a regent for producing libraries for
analyzing the BRCA ½ genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.
Model: NextSeq 1000
Manufacturer: Illumina
Origin: Singapore/United States
Launching year: 01/2020
The PANA RealTyper™ HPV Screening Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC
PANA RealTyperTM HPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.
DxFLEX is a new clinical flow cytometry platform derived from the successful CytoFLEX. The advanced sensitivity and intuitive software DxFLEX makes flow cytometry routine for both novice and expert flow cytometry technicians and promotes standardization. Functionality in the autoloader facilitates accurate results and sample tracking.
Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time
Model: iSeq 100
Manufacturer: Illumina/USA
Illumina’s smallest next-generation DNA sequencing system, with small, fast and efficient sequencing throughput, suitable for all labs
– Fast data generation: Suitable for small projects, on a dedicated device, low throughput with fast turnaround times
– Convenient operation: Control the sequencing process from start to finish and ensure independent sequencing instead of outsourcing.
Developed with cancer genomics experts in collaboration, oligos ready-to-use, pre-engineered oligos allow researchers to sequence a wide range of genes and single nucleotide polymorphisms (SNPs) in advance. this is related to cancer predisposition
Assisted Reproductive 
Prenatal screening 
New-born screening 
Screening 
Diagnosis 
Early detection 
Monitoring 
Illumina infectious diseases testing group 
GeneProof infectious diseases testing group 
Panagene infectious diseases testing group 
Digital forensics 
Inspection of Ballistics and Mechanical Traces 
Document examination 
Crime scene examination 
